TY - JOUR
T1 - Strong correlation of novel sleep electroencephalography coherence markers with diagnosis and severity of posttraumatic stress disorder
AU - Modarres, Mo H.
AU - Opel, Ryan A.
AU - Weymann, Kristianna B.
AU - Lim, Miranda M.
N1 - Funding Information:
The authors would like to express their sincere appreciation and gratitude for the participation of all subjects, to the staff at the VA Portland Health Care System Sleep Disorders Clinic, and to Yvonne Barsalou and Dennis Pleshakov for assistance with data collection and database entry. This material is the result of work supported with resources and the use of facilities of the Brain Rehabilitation Research Center (BRRC) at Malcom Randall VA Gainesville, Office of Rehabilitation Research and Development Award #2192-P, the BBRC Pilot Award 0217BRRC-01 to M.H.M., and the VA RR&D SPiRE Award # 1 l21 RX001923-01A1 to M.H.M. and M.M.L. Work was also supported by resources and facilities at the VA Portland Health Care System, VA Career Development Award #IK2 BX002712, NIH EXITO Institutional Core # UL1GM118964, and the Portland VA Research Foundation to M.M.L.; and VA OAA Post-doctoral Nursing Research Fellowship to K.B.W. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.
Publisher Copyright:
© 2019, The Author(s).
PY - 2019/12/1
Y1 - 2019/12/1
N2 - Objective biomarkers of the presence and severity of posttraumatic stress disorder (PTSD) are elusive, yet badly needed. Electroencephalographic (EEG) coherence represents a promising approach to identifying and understanding brain biomarker activity in PTSD. Overnight polysomnography data containing EEG across sleep and wake states was collected in n = 76 Veterans with and without PTSD from a single site under IRB approval. Brain coherence markers (BCM) were calculated from EEG signals using a novel approach to produce one index for PTSD diagnosis (PTSD dx ), and another index for PTSD severity (PTSD sev ). PTSD dx showed strong sensitivity to the presence of PTSD in the awake state, during non-rapid eye movement (NREM) stage N2 sleep, and in a hybrid BCM incorporating both awake and NREM sleep states. PTSD sev showed a strong correlation with PTSD symptom severity (using the PTSD Checklist 5, or PCL5 survey) in the awake state, during N2 sleep, and in a hybrid BCM incorporating both awake and NREM sleep states. Thus, sleep EEG-based brain coherence markers can be utilized as an objective means for determining the presence and severity of PTSD. This portable, inexpensive, and non-invasive tool holds promise for better understanding the physiological mechanisms underlying PTSD and for tracking objective responses to treatment.
AB - Objective biomarkers of the presence and severity of posttraumatic stress disorder (PTSD) are elusive, yet badly needed. Electroencephalographic (EEG) coherence represents a promising approach to identifying and understanding brain biomarker activity in PTSD. Overnight polysomnography data containing EEG across sleep and wake states was collected in n = 76 Veterans with and without PTSD from a single site under IRB approval. Brain coherence markers (BCM) were calculated from EEG signals using a novel approach to produce one index for PTSD diagnosis (PTSD dx ), and another index for PTSD severity (PTSD sev ). PTSD dx showed strong sensitivity to the presence of PTSD in the awake state, during non-rapid eye movement (NREM) stage N2 sleep, and in a hybrid BCM incorporating both awake and NREM sleep states. PTSD sev showed a strong correlation with PTSD symptom severity (using the PTSD Checklist 5, or PCL5 survey) in the awake state, during N2 sleep, and in a hybrid BCM incorporating both awake and NREM sleep states. Thus, sleep EEG-based brain coherence markers can be utilized as an objective means for determining the presence and severity of PTSD. This portable, inexpensive, and non-invasive tool holds promise for better understanding the physiological mechanisms underlying PTSD and for tracking objective responses to treatment.
UR - http://www.scopus.com/inward/record.url?scp=85062827768&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062827768&partnerID=8YFLogxK
U2 - 10.1038/s41598-018-38102-4
DO - 10.1038/s41598-018-38102-4
M3 - Article
C2 - 30862872
AN - SCOPUS:85062827768
SN - 2045-2322
VL - 9
JO - Scientific Reports
JF - Scientific Reports
IS - 1
M1 - 4247
ER -